http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2367467-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1baff56769e999845e795c40b6899bf4 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 |
| filingDate | 2007-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d86e00d5f6b2e5179c9f5bffb96f799 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c3a9fd86b28af3ffda0dc9ce914377c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1b7d2835c29448998d0f2d378527084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a51ceeca3e0c668dc64a85da1dfa34de |
| publicationDate | 2009-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2367467-C2 |
| titleOfInvention | Peptide pharmaceutical composition normalising urination, and method of application thereof |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medical agents normalising urination, and can be used as means for correction of dysuric disorders of various geneses, including caused by infectious-inflammatory and neuroendocrinological factors. There is declared pharmaceutical composition normalising urination, containing as a reactant, peptide glutamyl- aspartic acid in effective amount of general formula: H-Glu-Asp-OH of a sequences 1 [SEQ ID NO:1] and a pharmaceutically acceptable carrier. There is declared agent containing peptide- aspartic acid of general formula: H-Glu-Asp-OH of a sequence 1 [SEQ ID NO:1] showing biological activity with regard to normalising urination. There is disclosed method of detrusor-sphincter continence consisting in introduction to the patient of the pharmaceutical composition containing as a reactant, peptide glutamyl- aspartic acid in effective amount of general formula: H-Glu-Asp-OH of a sequence 1 [SEQ ID NO:1]. n EFFECT: enabled normalising of urination by detrusor-sphincter continence. n 5 cl, 6 ex, 3 tbl, 2 dwg |
| priorityDate | 2007-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 137.